$STXS Gap. Pr $1.26
Nasdaq GM
Stereotaxis Niobe® ES System Installed at Texas Children’s
Hospital Globe Newswire(Fri, Jul
Website
Low Float
Shares Outstanding: 21.67M
Float: 16.90M
% Held by Insiders: 15.52%
% Held by Institutions: 16.80%
Shares Short (as of Jun 15, 2016): 252.79K
Short Ratio (as of Jun 15, 2016): 9.22
Short % of Float (as of Jun 15, 2016): 1.28%
Shares Short (prior month): 285.84K
Headlines
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks worldwide. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters; and Pegasus coronary guidewire for cardiology procedures. Further, the companys disposables and other accessories include V-CAS catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. Stereotaxis, Inc. has strategic alliances with Siemens AG Medical Solutions; Philips Medical Systems; and Biosense Webster, Inc. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
Nasdaq GM
Stereotaxis Niobe® ES System Installed at Texas Children’s
Hospital Globe Newswire(Fri, Jul
Website
Low Float
Shares Outstanding: 21.67M
Float: 16.90M
% Held by Insiders: 15.52%
% Held by Institutions: 16.80%
Shares Short (as of Jun 15, 2016): 252.79K
Short Ratio (as of Jun 15, 2016): 9.22
Short % of Float (as of Jun 15, 2016): 1.28%
Shares Short (prior month): 285.84K
Headlines
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks worldwide. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters; and Pegasus coronary guidewire for cardiology procedures. Further, the companys disposables and other accessories include V-CAS catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. Stereotaxis, Inc. has strategic alliances with Siemens AG Medical Solutions; Philips Medical Systems; and Biosense Webster, Inc. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
